Cargando…

The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes

OBJECTIVE: To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes. DESIGN: We studied the relationship between baseline,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lind, Marcus, Tuomilehto, Jaakko, Uusitupa, Matti, Nerman, Olle, Eriksson, Johan, Ilanne-Parikka, Pirjo, Keinänen-Kiukaanniemi, Sirkka, Peltonen, Markku, Pivodic, Aldina, Lindström, Jaana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186853/
https://www.ncbi.nlm.nih.gov/pubmed/25285769
http://dx.doi.org/10.1371/journal.pone.0109506
_version_ 1782338124811075584
author Lind, Marcus
Tuomilehto, Jaakko
Uusitupa, Matti
Nerman, Olle
Eriksson, Johan
Ilanne-Parikka, Pirjo
Keinänen-Kiukaanniemi, Sirkka
Peltonen, Markku
Pivodic, Aldina
Lindström, Jaana
author_facet Lind, Marcus
Tuomilehto, Jaakko
Uusitupa, Matti
Nerman, Olle
Eriksson, Johan
Ilanne-Parikka, Pirjo
Keinänen-Kiukaanniemi, Sirkka
Peltonen, Markku
Pivodic, Aldina
Lindström, Jaana
author_sort Lind, Marcus
collection PubMed
description OBJECTIVE: To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes. DESIGN: We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study. SETTING: Follow-up of clinical trial. PARTICIPANTS: 504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c. MAIN OUTCOME MEASURE: Relative risk of CVD. RESULTS: Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p<0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD. CONCLUSIONS AND RELEVANCE: Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes.
format Online
Article
Text
id pubmed-4186853
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41868532014-10-16 The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes Lind, Marcus Tuomilehto, Jaakko Uusitupa, Matti Nerman, Olle Eriksson, Johan Ilanne-Parikka, Pirjo Keinänen-Kiukaanniemi, Sirkka Peltonen, Markku Pivodic, Aldina Lindström, Jaana PLoS One Research Article OBJECTIVE: To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes. DESIGN: We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study. SETTING: Follow-up of clinical trial. PARTICIPANTS: 504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c. MAIN OUTCOME MEASURE: Relative risk of CVD. RESULTS: Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p<0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD. CONCLUSIONS AND RELEVANCE: Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes. Public Library of Science 2014-10-06 /pmc/articles/PMC4186853/ /pubmed/25285769 http://dx.doi.org/10.1371/journal.pone.0109506 Text en © 2014 Lind et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lind, Marcus
Tuomilehto, Jaakko
Uusitupa, Matti
Nerman, Olle
Eriksson, Johan
Ilanne-Parikka, Pirjo
Keinänen-Kiukaanniemi, Sirkka
Peltonen, Markku
Pivodic, Aldina
Lindström, Jaana
The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
title The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
title_full The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
title_fullStr The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
title_full_unstemmed The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
title_short The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
title_sort association between hba1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186853/
https://www.ncbi.nlm.nih.gov/pubmed/25285769
http://dx.doi.org/10.1371/journal.pone.0109506
work_keys_str_mv AT lindmarcus theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT tuomilehtojaakko theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT uusitupamatti theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT nermanolle theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT erikssonjohan theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT ilanneparikkapirjo theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT keinanenkiukaanniemisirkka theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT peltonenmarkku theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT pivodicaldina theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT lindstromjaana theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT lindmarcus associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT tuomilehtojaakko associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT uusitupamatti associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT nermanolle associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT erikssonjohan associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT ilanneparikkapirjo associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT keinanenkiukaanniemisirkka associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT peltonenmarkku associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT pivodicaldina associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes
AT lindstromjaana associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes